Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New Two-Pronged cancer drug seeks best dose in fight against aggressive lung cancer
Disease control Recruiting nowThis study aims to find the best dose of a new drug called ivonescimab when used with standard chemotherapy for extensive-stage small cell lung cancer. Ivonescimab is designed to help the immune system attack cancer and block the tumor's blood supply. About 60 adults who have not…
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Real-World lung cancer treatment study seeks to uncover which standard regimen works best
Disease control Recruiting nowThis study aims to collect information from routine medical practice to better understand the safety and effectiveness of two standard treatment options for advanced lung cancer with a specific genetic change (EGFR mutation). It will observe about 538 patients who are already rec…
Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC